AzTrials
AzTrials

HealthyNCT07490665

Impact of Artificial Intelligence Discussion on Midwifery Students

A study testing Experimental AI Case Group in people with Healthy and Student, run by Fenerbahce University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aimed to examine the effect of artificial intelligence-assisted case discussions on midwifery students' use and proficiency of artificial intelligence technologies and their clinical competency levels. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy, Student
What is being tested?
Experimental AI Case Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
81 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Mar 2026to 20 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Being a 3rd/4th year student in the Midwifery department
  • Having previously taken courses on Healthy and High-Risk Pregnancy
  • Having prepared and presented at least one midwifery care plan

Who cannot join

  • Using more than 20% absenteeism in field applications

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayşe G Bursa, Assistant Professor contact

+905062984670

aysegul.bursa@fbu.edu.tr

Sinem Dinmez, Assistant Professor contact

+905063568804

Turkey (Türkiye)1 site
  • Fenerbahce University

    Istanbul, Atasehır, 34758

Other trials in Turkey (Türkiye)

About this study

Official title: The Impact of Artificial Intelligence-Assisted Case Discussion on Artificial Intelligence Attitude, Usage and Proficiency Among Midwifery Students

This study aimed to examine the effect of artificial intelligence-assisted case discussions on midwifery students' use and proficiency of artificial intelligence technologies and their clinical competency levels. With the rapid development of artificial intelligence, its integration into healthcare education has become increasingly important. Supporting case-based learning with AI tools may enhance students' clinical decision-making, problem-solving, and critical thinking skills. Therefore, this study evaluates the contribution of AI-assisted educational approaches to the professional development of midwifery students.

Read the detailed description

Artificial intelligence (AI), which refers to computer-supported systems capable of performing tasks that require human intelligence, has become increasingly popular in all fields in recent years. AI is a technological system that can think, learn, perceive, make predictions, communicate, and make decisions like humans-or even better than humans. In short, AI can be described as a broad scientific field that simulates the natural intelligence demonstrated by humans through artificial means.

The ability of AI to process the data presented to the system, perform data analyses, generate new ideas, and reach different conclusions has increased the use of AI. These features may surpass human problem-solving and decision-making abilities in terms of speed, efficiency, and quality. Due to these advantages, the use of artificial intelligence in midwifery education has become inevitable.

The Australian College of Midwives (ACM) established the Select Committee on Adopting Artificial Intelligence in March 2024 to support and regulate the adoption of AI. This committee emphasized the necessity and priority of using AI in midwifery education. It also highlighted that midwives should be trained in the use of AI and should be an integral part of the design, implementation, and evaluation of all AI tools used in maternity care (ACM, 2024).

Regarding the use of AI in healthcare, the World Health Organization (WHO) has identified three strategic plans: enabling evidence-based standards, governance, policies, and guidance; facilitating shared investments and a global community of expertise; and implementing sustainable models for the adoption of AI programs at the country level (WHO, 2024). In line with these strategies, it is necessary to integrate AI applications into the midwifery profession.

With the influence of rapidly evolving technology, it has become inevitable to improve midwifery education. In traditional education methods, the instructor plays an active role while students remain passive. However, for learning to be effective, opportunities should be created for students to actively practice their skills and develop critical thinking abilities. Case-based learning in midwifery education is a method that can improve students' logical, clinical, and participatory skills while increasing their knowledge levels.

Supporting case-based learning with artificial intelligence tools can contribute to more accurate diagnosis and the development of clinical decision-making and problem-solving skills. In this way, it becomes possible to educate competent midwives who are confident and capable of using technology effectively.

The aim of this study is to examine the effect of artificial intelligence-assisted case discussions on midwifery students' use and proficiency of artificial intelligence technologies and their clinical competency levels.

Conditions
Healthy, Student
Being tested
Experimental AI Case Group
Keywords
Artificial Intelligence, Midwifery, Clinical Competence, Problem-Based Learning, Health Occupations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental AI Case GroupBehavioural

    Students in the experimental group will be presented with a case scenario and given 30 minutes to review it. During this time, they will be asked to develop a care plan for the case. Subsequently, within a 60-minute session, the researcher will present a care plan prepared with artificial intelligence assistance for the same case. A case discussion will then be conducted by comparing the care plans developed by the students with the AI-assisted care plan.

Study groups in NCT07490665
Study groupRoleWhat they receive
AI Case GroupExperimentalStudents in the experimental group will be presented with a case scenario and given 30 minutes to review it. During this time, they will be asked to develop a care plan for the case. Subsequently, within a 60-minute session, the researcher will present a care plan prepared with artificial intelligence assistance for the same case. A case discussion will then be conducted by comparing the care plans developed by the students with the AI-assisted care plan.
Receives: Behavioral: Experimental AI Case Group
ControlNo interventionDiscussion of routinely implemented maintenance plan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of artificial intelligence usage

    Changes in the level of AI usage among midwifery students after training, compared to baseline values. The Student Attitudes toward Artificial Intelligence Scale (SATAI), developed in 2025, will be used for measurement.The scale, developed using a five-point Likert scale (1=Strongly disagree and 5=Strongly agree), does not contain any reverse-coded items. The highest possible score on the scale is 130, and the lowest is 26, with higher scores reflecting more positive attitudes towards artificial intelligence.

    Measured: Through study completion, an average of 3 months

  2. Usage and proficiency level

    This will be measured using the Generative Artificial Intelligence Use and Proficiency (GAAP) Scale, developed in 2024. Planned as a five-point Likert scale (fully reflecting = 5 points - not reflecting = 1 point), an increase in the score obtained from this scale indicates a high level of artificial intelligence use and proficiency. The minimum possible score on the scale is 19, and the maximum is 95.

    Measured: Through study completion, an average of 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2026
  2. Study start16 Mar 2026 (estimated)
  3. Primary completion8 Jun 2026 (estimated)
  4. Study completion20 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
As an intervention, an AI-powered maintenance plan will be discussed.
Masking
Single blind
Who is masked
Participant
Enrolment
81 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07490665
Sponsor's protocol ID
Fenerbahce U Midwifery
Status last verified
Mar 2026
First submitted
13 Mar 2026
Last updated
24 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We are not considering an explosion yet because data collection has not begun.

Questions about this trial

What is this clinical trial studying?

A study testing Experimental AI Case Group in people with Healthy and Student, run by Fenerbahce University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayşe G Bursa, Assistant Professor (+905062984670, aysegul.bursa@fbu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of artificial intelligence usage (time frame: Through study completion, an average of 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in